GWD-41080-78285

4 vaccinations 8 coded responses 40 check-ins 8 free-text entries 2 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 480 / MI
Registered: 2021-03-10

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-09
Dose 1 — Pfizer-BioNTech
2021-03-10
Registered in v-safe
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-16
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-23
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-30
Dose 2 — Pfizer-BioNTech
2021-03-30
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-04-06
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-15
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-20
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-27
Survey response — day 28, dose 2
MedDRA: Chills, Vertigo — Feeling: Fair · Be unable to work

Free text: Vertigo chills

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-11
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-01
Survey response — 3 months, dose 2
MedDRA: Parosmia — Feeling: Good

Free text: When cry or sneeze, smell antiseptic/chlorine. Not around any.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-06
Dose 3 — Pfizer-BioNTech
2021-10-08
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Swollen lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2021-10-10
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Swollen lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2021-10-12
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-13
Health check-in — day 7, dose 3
Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-20
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-10-29
Survey response — day 21, dose 3
MedDRA: Dyspnoea, Parosmia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Short of breath, changes in smell

MedDRA releases: 2024-11 · check-in free text available
2021-11-03
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-11-11
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2021-11-17
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-01-05
Survey response — 3 months, dose 3
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid

MedDRA releases: 2024-11 · check-in free text available
2022-01-05
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-07
Call 1 — Left Voicemail
2022-01-07
Call successful
Participant prefers to complete VAERS report online
2022-09-09
Dose 4 — Pfizer-BioNTech
2022-09-09
Health check-in — day 0, dose 4
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school

Adult check-in
2022-09-10
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-09-11
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site

Adult check-in
2022-09-12
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site

Adult check-in
2022-09-16
Health check-in — day 7, dose 4
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2022-09-23
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-02
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-10-07
Survey response — day 28, dose 4
MedDRA: Pyrexia, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activities

Free text: Feverish, runny nose, sneezing

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Survey response — 3 months, dose 4
MedDRA: Bell's palsy — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Bell's palsy

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Report sent to call center — 3 months, dose 4
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-09	Pfizer-BioNTech
2	2021-03-30	Pfizer-BioNTech
3	2021-10-06	Pfizer-BioNTech	No
4	2022-09-09	Pfizer-BioNTech	No

Call center

2 call center cases

1 successful · 1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 8 — day 28, dose 2

2021-04-27

Symptoms: Vertigo chills

Release 9 — 3 months, dose 2

2021-07-01

Symptoms: When cry or sneeze, smell antiseptic/chlorine. Not around any.

Release 10 — days 1–6 daily, dose 3

2021-10-08

Systemic reaction (other): Swollen lymph nodes

2021-10-10

Systemic reaction (other): Swollen lymph nodes

Release 10 — day 21, dose 3

2021-10-29

Symptoms: Short of breath, changes in smell

Release 10 — 3 months, dose 3

2022-01-05

Symptoms: Covid

Release 12 — day 28, dose 4

2022-10-07

Symptoms: Feverish, runny nose, sneezing

Release 12 — 3 months, dose 4

2022-12-09

Symptoms: Bell's palsy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bell's palsy	·	·	✓
SD	Chills	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Parosmia	✓	✓	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Sneezing	·	·	✓
SD	Vertigo	✓	✓	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release